CS logo
small CS logo
ECMC Ambulatory Center, 3rd Floor

Buffalo, New York, United States

About ECMC Ambulatory Center, 3rd Floor


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at ECMC Ambulatory Center, 3rd Floor


During the past decade, ECMC Ambulatory Center, 3rd Floor conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "ECMC Ambulatory Center, 3rd Floor" #1 collaborator was "Kaleida Health" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Harvard Medical School (HMS and HSDM)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at ECMC Ambulatory Center, 3rd Floor


According to Clinical.Site data, the most researched conditions in "ECMC Ambulatory Center, 3rd Floor" are "Type 2 Diabetes" (3 trials), "Appetite Loss" (1 trials), "Evaluate Ketogenic Stress" (1 trials), "Postprandial Inflammation" (1 trials) and "Type 1 Diabetes" (1 trials). Many other conditions were trialed in "ECMC Ambulatory Center, 3rd Floor" in a lesser frequency.

Clinical Trials Intervention Types at ECMC Ambulatory Center, 3rd Floor


Most popular intervention types in "ECMC Ambulatory Center, 3rd Floor" are "Drug" (5 trials), "Dietary Supplement" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Dapagliflozin" (2 trials), "Dapagliflozin placebo" (1 trials), "Exenatide/Exenatide extended release" (1 trials) and "Farxiga" (1 trials). Other intervention names were less common.

Clinical Trials Genders at ECMC Ambulatory Center, 3rd Floor


The vast majority of trials in "ECMC Ambulatory Center, 3rd Floor" are 8 trials for "All" genders.

Clinical Trials Status at ECMC Ambulatory Center, 3rd Floor


Currently, there are NaN active trials in "ECMC Ambulatory Center, 3rd Floor". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in ECMC Ambulatory Center, 3rd Floor, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in ECMC Ambulatory Center, 3rd Floor, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".